Showing results (191-200 of 475) with videos related to
Sort By:
Pageof 48
European Journal of Nuclear Medicine|January 1, 1982
Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasiaM Fischer, W Vetter, B Winterg, et al.Clinical and Experimental Hypertension|January 1, 1981
Intracellular Na+ as a genetic marker of essential hypertensionH Losse, W Zidek, H Zumkley, et al.Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|January 24, 1989
[Exertional dyspnea, fatigue, palpitations]J C Geller, U H Barkow, K Glänzer, et al.Nephron|January 1, 1986
Captopril and kidney function in renovascular and essential hypertensionP Greminger, H Vetter, J Steurer, et al.Schweizerische Medizinische Wochenschrift|September 25, 1976
[Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome]W Vetter, H Vetter, R Beckerhoff, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1983
Sodium and calcium in lymphocytes and erythrocytes in essential hypertensionW Zidek, M Knorr, H Losse, et al.Hepato-Gastroenterology|January 1, 1997
Calcium modulates the synthesis of prostaglandin E2 in isolated colonic mucosal cellsC Schmidt, S Ramachers, B Baumeister, et al.International Journal of Clinical Pharmacology Research|January 1, 1990
Baroreceptor activity in man during administration of the calcium channel blocker felodipineB Weisser, P Lieder, B Göbel, et al.Klinische Wochenschrift|April 15, 1985
Hemodynamic, renal, and hormonal responses to changes in dietary potassium in normotensive and hypertensive man: long-term antihypertensive effect of potassium supplementation in essential hypertensionA Overlack, K O Stumpe, B Moch, et al.Psychosomatic Medicine|July 1, 1987
Long-term effects of a complex behavioral treatment of essential hypertensionH Lehnert, K Kaluza, H Vetter, et al.Pageof 48